Patient Recruitment/Retention Featured Articles

31. Developing A Diversity Action Plan That Actually Works 12/7/2023

    A successful diversity action plan (DAP) requires contributions of multiple cross-functional teams who are collectively well resourced and financed. Consultant Devra Densmore explains.

32. How To Measure Progress In Improving Clinical Trial Diversity 11/22/2023

    CTTI Diversity project’s makes recommendations for more diverse clinical trials and presents a maturity model to help sponsors develop or improve sustained clinical trial research infrastructure.

33. Best Practices For Conducting Clinical Trials In Africa 11/21/2023

    With its rich ethnic diversity, low trial density, and developing healthcare infrastructures, Africa is poised to become the next frontier of clinical research.

34. How Pfizer Prioritizes Diversity When Implementing Multiple Myeloma Trials 11/21/2023

    Every patient deserves the chance to feel seen, heard, and prioritized in research and care — and for Black individuals with multiple myeloma, it’s a matter of urgency. 

35. Medical Director, PI, And Educator: A 3D Perspective On Diverse Patient Enrollment 11/13/2023

    Based on experiences as a medical director, an IRB board member and PI, and an academician, Monique Gary, DO, MSc, FACS, FSSO, discusses diverse patient enrollment as well as ways in which sponsors, sites, advocates, and others can better serve minority and LGBTQ+ trial participants.

36. Understanding Rare Disease: Challenges And Opportunities 10/11/2023

    From retention to ethical and regulatory intricacies, there are many challenges associated with rare disease research. Explore how patient experience and advocacy groups are shaping breakthroughs.

37. Future Challenges And Predictions For CGT Patient-Focused Solutions 10/4/2023

    Leveraging innovative technologies to predict, model, and analyze data will enhance resource allocation, improve patient experience, reduce timelines, and drive cost efficiencies in the CGT industry.

38. Pfizer To Provide Individual Participant Data At Scale 9/21/2023

    Historically, clinical trial participants have rarely gained possession of their individual trial data. But now, that's about to change. Pfizer is announcing plans to return individual data to its participants beginning this year.

39. Patients Are Speaking, And We Must Listen 9/7/2023

    Maimah Karmo knows all too well the importance of speaking up for oneself. Here, the president and CEO of Tigerlily Foundation shares what drove her to create the nonprofit and why she won't stop advocating for patients.

40. What You Need To Know About The New ICH GCP E6(R3) Draft Guidelines 8/31/2023

    The ICH’s updated draft guidelines for planning, designing, conducting, recording, and reporting clinical trials introduce a dynamic, risk-based approach to trial design and create universal standards for data.